ACESO LIFE SCI (00474) announced its annual performance, reporting a net profit attributable to shareholders of HKD 338 million for the year, marking a return to profitability compared to the same period last year.
Xinming Life Science Technology (00474) announced its annual results for the year ended March 31, 2026, with continuing operations revenue of HK$58 million, a year-on-year increase of 16%; profit attributable to owners of the company for the year reached HK$338 million, returning to profit compared to the previous year; earnings per share were HK$0.0454.
ACESO LIFE SCI (00474) announced its financial results for the year ended March 31, 2026, reporting a revenue of HKD 58 million from continuing operations, a year-on-year increase of 16%. The profit attributable to owners of the company for the year was HKD 338 million, reversing the previous year's loss; earnings per share were HKD 4.54.
The announcement stated that the profit primarily came from the proceeds generated by the sale of an associated company (i.e., Haotian International Construction Investment) during the year.
Related Articles
Zhisheng Group Holdings (08370) has received a tender notification from a top social platform to provide approximately 500 megawatts of data center services.
C SUCCESS FIN(03623) has appointed Xu Kaiying as the chairman of the board.
GUOCO GROUP (00053): The annual profit attributable to the parent company's equity holders is 29.9 million, a decrease of 22.54% year-on-year.
Zhisheng Group Holdings (08370) has received a tender notification from a top social platform to provide approximately 500 megawatts of data center services.
C SUCCESS FIN(03623) has appointed Xu Kaiying as the chairman of the board.
GUOCO GROUP (00053): The annual profit attributable to the parent company's equity holders is 29.9 million, a decrease of 22.54% year-on-year.
RECOMMEND
